Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome
Clinical trial NCT02783547 · WITHDRAWN
Trial details
- NCT number
- NCT02783547
- Sponsor
- SymBio Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.